Vaping cessation has emerged as a critical health topic, especially given the skyrocketing rates among teens and young adults.A recent study highlighted that individuals aged 16 to 25 who utilized FDA-approved varenicline, a smoking cessation pill, were more than three times as successful at quitting vaping compared to their peers who only received behavioral counseling.
The Smoking Cessation Pill, varenicline, has emerged as a groundbreaking solution for those aiming to quit vaping, especially among teens and young adults.Recent research from Harvard-affiliated Mass General Brigham highlights that participants aged 16 to 25 who took this FDA-approved pill experienced over three times the success rate in quitting compared to those receiving only behavioral counseling.